Patterns and Predictors of Infection Following CAR T-cell Therapy: A Real-World Single-Center Experience

Key Points

• Infection rates post CAR T-cell therapy were notably high, impacting patient recovery and outcomes.
• Among 150 patients treated, 45% experienced infection, with early onset being a critical risk factor.
• Real-world data collected at a single center provided insights into post-therapy complications and management strategies.
• Understanding infection predictors can lead to better protocols and care standards for future CAR T therapies.